Azenta, Inc. (AZTA)
Price:
28.27 USD
( + 0.09 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Intuitive Surgical, Inc.
VALUE SCORE:
8
2nd position
LeMaitre Vascular, Inc.
VALUE SCORE:
9
The best
Pro-Dex, Inc.
VALUE SCORE:
10
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
NEWS
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
prnewswire.com
2026-02-24 16:05:00BURLINGTON, Mass., Feb. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond James 47th Annual Institutional Investor Conference, on Tuesday March 3rd, 2026, which includes a presentation beginning at 4:00 pm ET.
Rep. Gilbert Ray Cisneros, Jr. Buys Azenta, Inc. (NASDAQ:AZTA) Shares
defenseworld.net
2026-02-22 02:05:31Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Azenta, Inc. (NASDAQ: AZTA). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Azenta stock on January 15th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account. Representative Gilbert Ray
Financial Contrast: Mitesco (OTCMKTS:MITI) versus Azenta (NASDAQ:AZTA)
defenseworld.net
2026-02-20 01:33:20Azenta (NASDAQ: AZTA - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares Azenta and Mitesco"s
Caprock Group LLC Invests $1.64 Million in Azenta, Inc. $AZTA
defenseworld.net
2026-02-14 04:24:45Caprock Group LLC bought a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,707 shares of the company's stock, valued at approximately $1,640,000. Caprock Group LLC owned about 0.12% of
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
prnewswire.com
2026-02-09 16:05:00BURLINGTON, Mass., Feb. 9, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space.
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
seekingalpha.com
2026-02-04 14:00:49Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
prnewswire.com
2026-02-04 06:30:00BURLINGTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.
Privia Health Group (NASDAQ:PRVA) & Azenta (NASDAQ:AZTA) Financial Analysis
defenseworld.net
2026-02-02 01:44:50Privia Health Group (NASDAQ: PRVA - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Privia Health Group has a
Head-To-Head Survey: 10x Genomics (NASDAQ:TXG) & Azenta (NASDAQ:AZTA)
defenseworld.net
2026-01-31 01:46:5110x Genomics (NASDAQ: TXG - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations. Profitability This table compares 10x Genomics and Azenta's net
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
prnewswire.com
2026-01-21 16:05:00BURLINGTON, Mass., Jan. 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before the market opens.
Azenta, Inc. (NASDAQ:AZTA) Receives $41.83 Average Target Price from Analysts
defenseworld.net
2026-01-14 03:52:49Azenta, Inc. (NASDAQ: AZTA - Get Free Report) has been assigned an average recommendation of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and four have given a buy recommendation to the
New Strong Sell Stocks for January 8th
zacks.com
2026-01-08 05:51:05AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.
New Strong Sell Stocks for December 30th
zacks.com
2025-12-30 04:16:04ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
prnewswire.com
2025-12-29 08:00:00BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.
Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH)
defenseworld.net
2025-12-28 02:50:54Azenta (NASDAQ: AZTA - Get Free Report) and Nyxoah (NASDAQ: NYXH - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation. Volatility and Risk Azenta has a beta of 1.29,
New Strong Sell Stocks for Dec. 15
zacks.com
2025-12-15 06:51:08ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
prnewswire.com
2026-02-24 16:05:00BURLINGTON, Mass., Feb. 24, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Raymond James 47th Annual Institutional Investor Conference, on Tuesday March 3rd, 2026, which includes a presentation beginning at 4:00 pm ET.
Rep. Gilbert Ray Cisneros, Jr. Buys Azenta, Inc. (NASDAQ:AZTA) Shares
defenseworld.net
2026-02-22 02:05:31Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of Azenta, Inc. (NASDAQ: AZTA). In a filing disclosed on February 13th, the Representative disclosed that they had bought between $1,001 and $15,000 in Azenta stock on January 15th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account. Representative Gilbert Ray
Financial Contrast: Mitesco (OTCMKTS:MITI) versus Azenta (NASDAQ:AZTA)
defenseworld.net
2026-02-20 01:33:20Azenta (NASDAQ: AZTA - Get Free Report) and Mitesco (OTCMKTS:MITI - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Valuation and Earnings This table compares Azenta and Mitesco"s
Caprock Group LLC Invests $1.64 Million in Azenta, Inc. $AZTA
defenseworld.net
2026-02-14 04:24:45Caprock Group LLC bought a new stake in shares of Azenta, Inc. (NASDAQ: AZTA) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 53,707 shares of the company's stock, valued at approximately $1,640,000. Caprock Group LLC owned about 0.12% of
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
prnewswire.com
2026-02-09 16:05:00BURLINGTON, Mass., Feb. 9, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge scientific experiments in space.
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
seekingalpha.com
2026-02-04 14:00:49Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
prnewswire.com
2026-02-04 06:30:00BURLINGTON, Mass., Feb. 4, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the first quarter ended December 31, 2025.
Privia Health Group (NASDAQ:PRVA) & Azenta (NASDAQ:AZTA) Financial Analysis
defenseworld.net
2026-02-02 01:44:50Privia Health Group (NASDAQ: PRVA - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends. Risk and Volatility Privia Health Group has a
Head-To-Head Survey: 10x Genomics (NASDAQ:TXG) & Azenta (NASDAQ:AZTA)
defenseworld.net
2026-01-31 01:46:5110x Genomics (NASDAQ: TXG - Get Free Report) and Azenta (NASDAQ: AZTA - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations. Profitability This table compares 10x Genomics and Azenta's net
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
prnewswire.com
2026-01-21 16:05:00BURLINGTON, Mass., Jan. 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal first quarter 2026 earnings which ended on December 31, 2025, on Wednesday, February 4, 2026, before the market opens.
Azenta, Inc. (NASDAQ:AZTA) Receives $41.83 Average Target Price from Analysts
defenseworld.net
2026-01-14 03:52:49Azenta, Inc. (NASDAQ: AZTA - Get Free Report) has been assigned an average recommendation of "Hold" from the nine ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and four have given a buy recommendation to the
New Strong Sell Stocks for January 8th
zacks.com
2026-01-08 05:51:05AZTA, BCBP and CLCO have been added to the Zacks Rank #5 (Strong Sell) List on January 8th, 2026.
New Strong Sell Stocks for December 30th
zacks.com
2025-12-30 04:16:04ASBFY, AZTA and ALG have been added to the Zacks Rank #5 (Strong Sell) List on December 30, 2025.
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
prnewswire.com
2025-12-29 08:00:00BURLINGTON, Mass. , Dec. 29, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that its affiliate, Azenta Germany GmbH, has signed a binding agreement for the sale of Azenta's B Medical Systems business to THELEMA S.
Contrasting Azenta (NASDAQ:AZTA) and Nyxoah (NASDAQ:NYXH)
defenseworld.net
2025-12-28 02:50:54Azenta (NASDAQ: AZTA - Get Free Report) and Nyxoah (NASDAQ: NYXH - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations and valuation. Volatility and Risk Azenta has a beta of 1.29,
New Strong Sell Stocks for Dec. 15
zacks.com
2025-12-15 06:51:08ALG, AZTA and CMG have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 15, 2025.